(Q44699388)

5 December 2017

title

DeltaNp73 stabilises TAp73 proteins but compromises their function due to inhibitory hetero-oligomer formation (English)

1 reference

5 December 2017

N Slade

1

1 reference

5 December 2017

A I Zaika

series ordinal

2

1 reference

5 December 2017

S Erster

series ordinal

3

1 reference

5 December 2017

U M Moll

series ordinal

4

1 reference

5 December 2017

publication date

1 March 2004

1 reference

Cell Death & Differentiation

5 December 2017

published in

1 reference

5 December 2017

volume

11

1 reference

5 December 2017

issue

3

1 reference

5 December 2017

page(s)

357-360

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.cdd.4401335

5 December 2017

exact match

0 references

cites work

p73: Friend or foe in tumorigenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401335

p53 polymorphism influences response in cancer chemotherapy via modulation of p73-dependent apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401335

p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401335

An anti-apoptotic role for the p53 family member, p73, during developmental neuron death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401335

DeltaNp73, a dominant-negative inhibitor of wild-type p53 and TAp73, is up-regulated in human tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401335

Transactivation-deficient p73alpha (p73Deltaexon2) inhibits apoptosis and competes with p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401335

Transactivation-deficient Delta TA-p73 inhibits p53 by direct competition for DNA binding: implications for tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401335

p53 induces the expression of its antagonist p73 Delta N, establishing an autoregulatory feedback loop

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401335

Human delta Np73 regulates a dominant negative feedback loop for TAp73 and p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401335

Autoinhibitory regulation of p73 by Delta Np73 to modulate cell survival and death through a p73-specific target element within the Delta Np73 promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401335

deltaNp73 facilitates cell immortalization and cooperates with oncogenic Ras in cellular transformation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401335

DeltaN-p73alpha accumulates in human neuroblastic tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401335

Mdm2 binds p73 alpha without targeting degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401335

MDM2 suppresses p73 function without promoting p73 degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401335

Covalent modification of p73alpha by SUMO-1. Two-hybrid screening with p73 identifies novel SUMO-1-interacting proteins and a SUMO-1 interaction motif

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401335

Expression of DeltaNp73 is a molecular marker for adverse outcome in neuroblastoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401335

inferred from DOI database lookup

7 January 2021

based on heuristic

Increased DeltaN-p73 expression in tumors by upregulation of the E2F1-regulated, TA-promoter-derived DeltaN'-p73 transcript

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401335

inferred from DOI database lookup

7 January 2021

based on heuristic

Inactivation of the p53-homologue p73 by the mdm2-oncoprotein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401335

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.CDD.4401335

1 reference

5 December 2017

1 reference